期刊文献+

银杏达莫注射液对急性脑梗死患者血清高敏C反应蛋白及神经功能的影响 被引量:2

Effects of Ginkgo dipyridolum injection on high sensitivity C-reactive protein and neurofunction in patients with acute cerebral infarction
下载PDF
导出
摘要 目的观察急性脑梗死患者使用银杏达莫前后血清高敏C反应蛋白(high sensitive C-reaction protein,hs-CRP)水平的变化及对神经功能的改善作用,探讨银杏达莫对急性脑梗死患者的疗效及可能机制。方法选择80例急性脑梗死患者随机分为治疗组和对照组各40例,银杏达莫(40例)给予银杏达莫注射液20ml溶于生理盐水250ml静滴,对照组(40例)给予丹参粉针400mg溶于生理盐250ml静滴,1次/d。连用15d。于治疗前后分别应用放射免疫比浊法检测治疗前和治疗后7d、15d的血清hs-CRP水平变化,且分别进行神经功能缺损程度评分。结果2组hs-CRP水平在梗死后7d最高,随后逐渐降低。治疗组治疗前血清hs-CRP水平和神经功能缺损评分与对照组比较差异无统计学意义(P>0.05);治疗后7d及15d治疗组hs-CRP水平神经功能缺损总分均低于对照组(P<0.01)。结论银杏达莫可降低患者血清hs-CRP水平,减轻炎症反应,改善缺损的神经功能。通过降低血清hs-CRP水平可能是其作用机制之一。 Objective To explore the effects of Ginkgo dipyridolum injection on high sensitivity C-reactive protein and neurofunction in patients with acute cerebral infarction. Methods Eighty patients with cerebral infarction were divided into two groups randomly. In treatment group(n=40), the patients were treated with 20 ml Ginkgo dipyridolum injection plus 250ml saline intravenously,once a day. Forty patients in control group were treated with radix injection 400 mg plus 250 ml saline intravenously, once a day. All treatment lasted for 15 days. The neurologie impairment scores were noted down and concentrations of soluble hs-CRP before the treatment and at 7d and 15d after the treatment. The level of serum hs-CRP was measured by scatter immune turbidity method. Results hs-CRP reached the highest level at 7d and then decreased slowly. The decline in serum level of hs-CRP at 7d and 15d of the treatment was more significant in the patients of treatment group than that in controlgroup(P〈0.01). The decline of the neurologic impairment scores at 7d and 15d of the treatment was more significant in the patients of treatment group than that of control group(P〈0.01). Conclusion Ginkgo dipyridolum injection can decrease serum hs-CRP and abate inflammatory reaction as well as improving impaired neurofunctions. Decreasing the level of serum hs-CRP may be one of the mechanisms of its effect.
出处 《中国实用神经疾病杂志》 2009年第19期8-10,共3页 Chinese Journal of Practical Nervous Diseases
关键词 脑梗死 银杏达莫 C反应蛋白 Cerebral infarction Ginkgo dipyridolum C-reaetive protein
  • 相关文献

参考文献10

  • 1Winbeck K,Poppert H,Etgen T,et al.Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke[J].Stroke,2002,33(11):2459-2464.
  • 2张江,王大力,张文彦,常莉莎,张丽.高敏C反应蛋白与脑梗死危险因素的相关性研究[J].中华老年心脑血管病杂志,2006,8(6):391-393. 被引量:19
  • 3Bulman N,Levy Y,Leiba R,et al.Increased C-reactive protein levels in the polycystic orary syndrome:a marker of cardiovascular disease[J].J Clin Endocrinol Metab,2004,89(5):2160-2165.
  • 4Torzewski J,Torzewski M,Bowyer DE,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
  • 5Rost NS,Wolf PA,Kase CS,et al.Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack:the Framingham study[J].Stroke,2001,32:2575-2579.
  • 6Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macro-phage colony-stimulating factor[J].J Exp Med,1992,176(6):1693-1702.
  • 7Montaner J,Fernandez Cadenas I,Molina CA,et al.Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis[J].Stroke,2006,37:1205.
  • 8曹红,孙长凯,赵杰,许晶,陶定波.脑梗死患者血清C-反应蛋白水平变化及临床意义[J].中华老年心脑血管病杂志,2005,7(4):248-250. 被引量:9
  • 9Paul SF,Karyn M,Cynthia DL.The neuroprotective properties of the Ginkgo biloba leaf:a review of the possible relationship to platelet activating factor(PAF)[J].J Ethnopharmacology,1996,50:131.
  • 10王小姗,狄晴,曹辉,张颖冬.银杏叶提取物对缺血再灌注鼠脑保护作用的研究[J].临床神经病学杂志,2006,19(1):53-55. 被引量:46

二级参考文献15

  • 1张萍.血清超敏C反应蛋白检测在脑血管疾病中的应用[J].中国血液流变学杂志,2004,14(2):254-255. 被引量:6
  • 2王雪松,阮旭中,刘买利.银杏叶提取物(GBE)对大鼠局灶性脑缺血后细胞间黏附分子-1及其mRNA表达的影响[J].中国现代应用药学,2003,20(6):441-444. 被引量:16
  • 3徐运,王岚,黄嵘,王翀,管得宁,王中原,朱琳,陶元祥.血小板活化因子通过N-甲基-D-天(门)冬氨酸/突触后密度蛋白93途径致神经元损伤[J].临床神经病学杂志,2005,18(1):13-15. 被引量:3
  • 4Dziedzic T, Gryz EA, Turaj W, et al. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients[J]. J Mol Neurosci, 2004,24: 293-298.
  • 5Silvestri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke[J]. J Am Geriatr Soc,2004 ,52:1586-1587.
  • 6Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke[J]. Stroke, 1999,30: 981-985.
  • 7Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hy-pertensive subjects[J]. Stroke, 2(K)4,35 : 1625-1630.
  • 8Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alphatocopherol, red yeast rice, and olive oil polyphenols. A review of the literature[J]. Altem Med Rev, 2001, 6:248-271.
  • 9Tohgi H, Konno S, Takahashi S, et al. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels[J].Thromb Res, 2000, 100: 373-379.
  • 10Nederkoom PJ, Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: A systematic review[J]. Stroke, 2003,34:1324-1334.

共引文献67

同被引文献30

引证文献2

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部